Answers are grounded in this paper and cite their sources.
Clinical trial tests an amorphic lens for mobility improvement in patients with retinitis pigmentosa, indicating potential benefits.
An amorphic lens, designed by William Fein‐bloom, was tested on 69 patients with retinitis pigmentosa. The results showed that one‐half of the patients experienced immediate improvement in mobility and one‐third of the patients fitted with the amorphic lens reported (after wearing the lenses for 2 weeks) improved mobility compared to their mobility before using the lens.
No takes yet. Share an insight, caveat, or question.
Hoeft et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: